EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation

Hanna Kucharczyk, Maciej Tarnowski iD, Marta Tkacz iD

Molecules · 17.12.2025 · 30 (24) · 4808

DOI: 10.3390/molecules30244808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 17.12.2025. Verfasst von Hanna Kucharczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Zolnierska 48, 70-210 Szczecin, P…. Hauptthemen laut MEDLINE: Neoplasms, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stromal/stem cells (MSCs) appear in many studies, and their utilization is a developing area of study. Scientists are investigating the abilities of MSCs and the possibilities of using them in anticancer therapies, as well as combining such therapies with those currently used clinically. This article provides an overview of MSC-based therapeutic strategies, assessing their potential in the context of cancer treatment. These are engineering or biotechnological approaches that utilize the natural properties of MSCs in a targeted and therapeutically effective manner. The review focuses on innovative methods such as genetic modifications to express desired therapeutic molecules, highlighting their potential applications in clinical practice. Innovative strategies include modifications to express anticancer proteins, miRNA (microRNA), siRNA (small interfering RNA), lncRNA (long non-coding RNA), and circRNA (circular RNA) that induce specific effects, as well as the delivery of therapeutic genes and oncolytic viruses. However, further studies are required to address the existing impediments, which are also discussed in this review. A major challenge in the clinical application of MSCs is their bidirectional role, an issue that remains a central focus of current research and is examined in this article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMesenchymal Stem CellsMesenchymal Stem Cell TransplantationHumansAnimalsGenetic TherapyTranslational Research, BiomedicalMicroRNAs

Stichwörter der Autor:innen

MSCsMSCs bidirectional rolecancercancer therapydrug carriersgenetic modifications

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Department of Physiology in Health Sciences, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, Zolnierska 48, 70-210 Szczecin, Poland.

ORCID-Profile: Maciej Tarnowski, Marta Tkacz

Zitieren

APA

Kucharczyk, H., Tarnowski, M., & Tkacz, M. (2025). Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation. Molecules, 30(24), 4808. https://doi.org/10.3390/molecules30244808

Vancouver

Kucharczyk H, Tarnowski M, Tkacz M. Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation. Molecules. 2025;30(24):4808. doi:10.3390/molecules30244808

BibTeX
@article{Kucharczyk2025,
  author = {Kucharczyk, Hanna and Tarnowski, Maciej and Tkacz, Marta},
  title = {Mesenchymal Stromal/Stem Cells (MSCs) in Cancer Therapy: Advanced Therapeutic Strategies Towards Future Clinical Translation},
  journal = {Molecules},
  year = {2025},
  volume = {30},
  number = {24},
  pages = {4808},
  doi = {10.3390/molecules30244808}
}
Kostenlos starten →